Clinical Trial Update: The Individually Marked Panretinal lasEr phoTokoagUlation for Proliferative Diabetic Retinopathy Study - DETECT [Phase 3]

View source ↗

Summary

Phase 3 DETECT trial evaluating individually marked panretinal laser photocoagulation for proliferative diabetic retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proliferative Diabetic Retinopathy

Snippet

Sponsor: Odense University Hospital | Conditions: Proliferative Diabetic Retinopathy | Phase 3 | Status: COMPLETED